The PEPperCHIP® Transglutaminase Microarray is based on 6 transglutaminase variants (hFXIII, hTG1, hTG2, hTG3, hTG4 and hTG6) and can be used for
- high resolution epitope mapping of anti-transglutaminase antibodies
- antibody specificity analysis with 6 different transglutaminase antigens
- serum antibody screening for anti-transglutaminase antibodies
- isotype-specific IgG and IgA profiling from serum and plasma
- correlation of anti-transglutaminase antibody responses with pathogenesis
The standard slide format of PEPperCHIP
® Transglutaminase Microarrays facilitates application with standard lab infrastructures and most microarray scanners. Additional PEPperCHIP
® Accessories support the straightforward use of the state-of-the-art peptide microarray solutions to ensure optimized assay conditions and best data quality.
Read more about PEPperCHIP Epitope Mapping Poster presentation at GRC, 2016 (Girona, Spain)
Successful ISO9001:2015 recertification
Dr. Falk Pharma and Zedira announce successful completion of the phase 2a proof-of-concept study of ZED1227 for the treatment of Celiac Disease
Dr. Falk Pharma und Zedira verkünden den erfolgreichen Abschluss der Phase 2a-Studie mit ZED1227 zur Behandlung von Zöliakie
Reversibly acting transglutaminase 2 inhibitors: drug candidates for the treatment of fibrosis
Design of Oral FXIIIa Blockers as Safer Anticoagulants – Mission Impossible?
Microbial transglutaminase (MTG) enables efficient and site-specific conjugation to native antibodies without the need of antibody engineering